Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Artelo Biosciences Inc (ARTL)

Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Artelo Biosciences Inc 505 LOMAS SANTA FE SUITE 160 SOLANA BEACH CA 92075 USA

www.artelobio.com P: 858-925-7049

Description:

Artelo Biosciences Inc. is a biopharmaceutical company. It is engaged in development and commercialization of proprietary therapeutics targeting the endocannabinoid system. The company's product pipeline consists of ART27.13, ART12.11 and ART26.12 which are in clinical stage. Artelo Biosciences Inc. is based in La Jolla, CA.

Key Statistics

Overview:

Market Capitalization, $K 4,228
Enterprise Value, $K 1,408
Shares Outstanding, K 3,228
Annual Sales, $ 0 K
Annual Net Income, $ -9,290 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,070 K
EBIT, $ -9,920 K
EBITDA, $ -9,920 K
60-Month Beta 1.45
% of Insider Shareholders 6.90%
% of Institutional Shareholders 0.87%
Float, K 3,005
% Float 93.10%
Short Volume Ratio 0.43

Growth:

1-Year Return -51.67%
3-Year Return -93.38%
5-Year Return -98.68%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 8.99%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.99 on 03/25/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -3.14
EPS Growth vs. Prev Qtr -19.28%
EPS Growth vs. Prev Year 16.10%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/10/22

ARTL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.68%
Return-on-Assets % -58.15%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.32
Book Value/Share 4.11
Interest Coverage -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar